ADMA Biologics
ADMA
#3367
Rank
HK$33.37 B
Marketcap
HK$139.87
Share price
-0.66%
Change (1 day)
-3.16%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: HK$33.37 Billion

As of January 2026 ADMA Biologics has a market cap of HK$33.37 Billion. This makes ADMA Biologics the world's 3367th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$33.37 B-6.76%
2025HK$35.79 B11.78%
2024HK$32.02 B301.46%
2023HK$7.97 B19.12%
2022HK$6.69 B211.06%
2021HK$2.15 B50.63%
2020HK$1.42 B-22.66%
2019HK$1.84 B113.01%
2018HK$0.86 B-23.67%
2017HK$1.13 B122.13%
2016HK$0.51 B-23.64%
2015HK$0.67 B-16.76%
2014HK$0.80 B43.24%
2013HK$0.56 B

End of Day market cap according to different sources

On Jan 9th, 2026 the market cap of ADMA Biologics was reported to be:

HK$33.28 Billion
by Nasdaq info icon info icon
HK$33.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novavax
NVAX
HK$9.20 B-72.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$73.17 B 119.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$0.35 B-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA